| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A note of thanks to referees for Volume 8, 2007
|
|
|
2007
|
|
8 |
p. 575-576
|
artikel
|
| 2 |
A note of thanks to referees Volume 7, 2006
|
|
|
2006
|
|
8 |
p. 558-559
|
artikel
|
| 3 |
Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients
|
Orlando, G
|
|
2006
|
|
8 |
p. 549-557
|
artikel
|
| 4 |
Authors' Reply to Drs JM Llibre, N Pérez-Alvarez & D Hall
|
Hill, A
|
|
2007
|
|
8 |
p. 571-572
|
artikel
|
| 5 |
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)
|
Gazzard, B
|
|
2006
|
|
8 |
p. 487-503
|
artikel
|
| 6 |
CD4 count and viral load time-courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system
|
Collazos, J
|
|
2006
|
|
8 |
p. 504-513
|
artikel
|
| 7 |
Contents
|
|
|
2006
|
|
8 |
p. 1-5
|
artikel
|
| 8 |
Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study
|
Rihs, TA
|
|
2006
|
|
8 |
p. 544-548
|
artikel
|
| 9 |
Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
|
Chetchotisakd, P
|
|
2007
|
|
8 |
p. 529-535
|
artikel
|
| 10 |
Evaluation of nevirapine-switch strategies for HIV treatment
|
Cooper, CL
|
|
2006
|
|
8 |
p. 537-543
|
artikel
|
| 11 |
Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors
|
Jain, MK
|
|
2007
|
|
8 |
p. 491-497
|
artikel
|
| 12 |
Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259–264
|
Llibre, JM
|
|
2007
|
|
8 |
p. 568-570
|
artikel
|
| 13 |
HIV in the UK 1980–2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy
|
Phillips, AN
|
|
2007
|
|
8 |
p. 536-546
|
artikel
|
| 14 |
Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients
|
Bugge, H
|
|
2007
|
|
8 |
p. 475-482
|
artikel
|
| 15 |
Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort
|
Handelsman, E
|
|
2007
|
|
8 |
p. 561-567
|
artikel
|
| 16 |
Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection
|
Adalid-Peralta, L
|
|
2006
|
|
8 |
p. 514-519
|
artikel
|
| 17 |
Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study
|
Poggensee, G
|
|
2007
|
|
8 |
p. 511-519
|
artikel
|
| 18 |
Improved cognitive function as a consequence of hepatitis C virus treatment *
|
Thein, HH
|
|
2007
|
|
8 |
p. 520-528
|
artikel
|
| 19 |
Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy *
|
Curkendall, SM
|
|
2007
|
|
8 |
p. 483-490
|
artikel
|
| 20 |
Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response
|
Fardet, L
|
|
2006
|
|
8 |
p. 520-529
|
artikel
|
| 21 |
Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
|
Bedimo, R
|
|
2006
|
|
8 |
p. 530-536
|
artikel
|
| 22 |
Peripheral arterial disease in HIV-infected and uninfected women
|
Sharma, A
|
|
2007
|
|
8 |
p. 555-560
|
artikel
|
| 23 |
Presence of M184I/V in minor HIV-1 populations of patients with lamivudine and/or didanosine treatment failure
|
Svedhem, V
|
|
2007
|
|
8 |
p. 504-510
|
artikel
|
| 24 |
Relative antiviral efficacy should not be inferred from cross-trial comparisons
|
Hall, D
|
|
2007
|
|
8 |
p. 570-571
|
artikel
|
| 25 |
Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000–2004 *
|
Bonnet, F
|
|
2007
|
|
8 |
p. 547-554
|
artikel
|
| 26 |
Validation of three-dimensional laser scanning for the assessment of facial fat changes
|
Paton, NI
|
|
2007
|
|
8 |
p. 498-503
|
artikel
|
| 27 |
Vanishing bile duct syndrome in a patient with advanced AIDS. HIV Med 2007; 8: 70–72
|
Aldeen, T
|
|
2007
|
|
8 |
p. 573-574
|
artikel
|
Tijdschrift beschrijving